News Column

Studies from University of Valencia Have Provided New Information about Health and Society (Predictability of pharmaceutical spending in primary...

August 1, 2014



Studies from University of Valencia Have Provided New Information about Health and Society (Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups)

By a News Reporter-Staff News Editor at Health & Medicine Week -- Research findings on Health and Medicine are discussed in a new report. According to news originating from Valencia, Spain, by NewsRx correspondents, research stated, "Risk adjustment instruments applied to existing electronic health records and administrative datasets may contribute to monitoring the correct prescribing of medicines. We aim to test the suitability of the model based on the CRG system and obtain specific adjusted weights for determined health states through a predictive model of pharmaceutical expenditure in primary health care."

Our news journalists obtained a quote from the research from the University of Valencia, "A database of 261,054 population in one health district of an Eastern region of Spain was used. The predictive power of two models was compared. The first model (ATC-model) used nine dummy variables: sex and 8 groups from 1 to 8 or more chronic conditions while in the second model (CRG-model) we include sex and 8 dummy variables for health core statuses 2-9. The two models achieved similar levels of explanation. However, the CRG system offers higher clinical significance and higher operational utility in a real context, as it offers richer and more updated information on patients."

According to the news editors, the research concluded: "The potential of the CRG model developed compared to ATC codes lies in its capacity to stratify the population according to specific chronic conditions of the patients, allowing us to know the degree of severity of a patient or group of patients, predict their pharmaceutical cost and establish specific programmes for their treatment."

For more information on this research see: Predictability of pharmaceutical spending in primary health services using Clinical Risk Groups. Health Policy, 2014;116(2-3):188-195. Health Policy can be contacted at: Elsevier Ireland Ltd, Elsevier House, Brookvale Plaza, East Park Shannon, Co, Clare, 00000, Ireland. (Elsevier - www.elsevier.com; Health Policy - www.elsevier.com/wps/product/cws_home/505962)

The news correspondents report that additional information may be obtained from D. Vivas-Consuelo, University of Valencia, Fac Econ, E-46003 Valencia, Spain. Additional authors for this research include R. Uso-Talarnantes, J.L. Trillo-Mata, M. Caballer-Tarazona, I. Barrachina-Martinez and L. Buigues-Pastor (see also Health and Medicine).

Keywords for this news article include: Valencia, Spain, Europe, Health and Medicine

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Medicine Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters